Follow The Filings

NEO NeoGenomics

NeoGenomics earnings company data as of 11:59 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by NEO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NEO insider trades
  • None no insider bought on the open market
  • $321K sold by 1 insider outside a trading plan
  • $646K sold by 3 insiders under 10b5-1 plans
  1. Greg D Aunan Chief Accounting Officer
    Sale
    $321K 20,000 shares at $16.07 80% of stake
    Traded Aug 4 Filed Aug 6
  2. Lynn A. Tetrault Director
    Planned sale
    $59K 5,307 shares at $11.10 5.8% of stake
    Traded Jun 15 Filed Jun 17
  3. Lynn A. Tetrault Director
    Planned sale
    $60K 5,307 shares at $11.29 5.5% of stake
    Traded Jun 9 Filed Jun 11
  4. Warren Stone COO
    Planned sale
    $277K 22,128 shares at $12.50 15% of stake
    Traded Jan 20 Filed Jan 21
  5. Alicia C Olivo EVP, GC & Business Development
    Planned sale
    $251K 20,916 shares at $12.00 40% of stake
    Traded Nov 25, 2025 Filed Nov 28, 2025
  6. Alicia C Olivo EVP, GC & Business Development
    Planned sale
    $49K 4,918 shares at $10.00 10% of stake
    Traded Oct 16, 2025 Filed Oct 20, 2025

Also filed in the last 12 months, not counted as buying or selling: 26 option exercises and 22 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
8-K 2.02,5.02,5.03,9.01
SCHEDULE 13G/A —
8-K 5.02
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K/A 7.01,8.01,9.01
8-K 7.01,8.01,9.01
8-K 5.02,7.01,9.01
8-K 1.01,2.03,3.02,8.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
8-K 5.02,5.07,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G —
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.